BUSINESS● LOW2h ago · Oct 30, 2026, 12:17 PM
AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan
EuroNews [en] · global
AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS23m agoAs energy prices threaten inflation again, Lagarde’s European Central Bank legacy offers lessonsAtlantic CouncilBUSINESS25m agoLiveRamp ticks higher as it's set to be delisted before Monday open on Publicis dealSeeking Alpha Tech